Form 4: Align Technology CEO Hogan Reports Share Transactions

Align Technology's President and CEO, Joseph M. Hogan, reported the acquisition of common stock through derivative exercises and the sale of shares for tax obligations.

Summary

• Joseph M. Hogan, President and CEO of Align Technology, reported transactions involving company stock on February 20, 2026.
• Acquired 40,248 shares of common stock through the exercise of derivative securities at a price of $0.
• Disposed of 16,107 shares of common stock at $190.02 per share to cover tax liabilities associated with equity award vesting.
• Beneficial ownership after these transactions includes 209,270 direct shares, 55,267 indirect shares held by the Hogan 2025 GRAT, and 1,500 indirect shares held by his spouse.
• New grants on February 20, 2026, include 19,144 Restricted Stock Units (RSUs) and 44,670 Market Stock Units (MSUs).
• Several tranches of previously granted equity awards vested on February 20, 2026, including 3,961 RSUs (from a 2025 grant), 1,865 RSUs (from a 2022 grant), 3,672 RSUs (from a 2023 grant), 3,397 RSUs (from a 2024 grant), and 27,353 MSUs (from a 2023 grant).
• The reported transactions also include 184 shares acquired on January 30, 2026, under the ALGN Employee Stock Purchase Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting routine executive compensation activities including new equity grants and vesting of existing awards, which aligns management incentives with long-term company performance, despite a necessary tax-related share disposal.

Positives

• Acquisition of 40,248 shares of common stock through derivative exercises, indicating the conversion of equity awards into direct ownership.
• Grant of 19,144 new Restricted Stock Units (RSUs) and 44,670 new Market Stock Units (MSUs) on February 20, 2026, aligning management incentives with long-term company performance.
• Vesting of multiple tranches of previously granted equity awards (RSUs and MSUs) on February 20, 2026, demonstrating ongoing compensation and retention of key executives.
• Acquisition of 184 shares under the ALGN Employee Stock Purchase Plan, showing continued participation in employee ownership programs.

Negatives

• Disposal of 16,107 shares of common stock at $190.02 per share to satisfy tax withholding obligations related to equity award vesting.

Future Outlook

The filing indicates future vesting schedules for newly granted Restricted Stock Units, with 1/4th vesting annually starting February 20, 2027. Market Stock Units granted on February 20, 2026, will vest on the last day of the third year of their performance period, with a potential maximum payout of 250% of the target amount based on performance.

Industry Context

StockSavvy.ai notes that these insider transactions are routine disclosures for executive compensation, reflecting the typical structure of long-term incentive plans in the medical device and technology sectors. The mix of RSUs and MSUs is common for aligning executive interests with shareholder value over multi-year performance periods, similar to practices at peers like Dentsply Sirona or Zimmer Biomet.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) and Market Stock Units (MSUs) for executive compensation is a standard practice across the S&P 500, particularly in high-growth technology and medical device companies like Align Technology. This structure is designed to incentivize long-term performance and retention, similar to compensation packages observed at companies such as Intuitive Surgical (ISRG) or Stryker Corporation (SYK).
• The disposal of shares to cover tax obligations upon vesting (a 'net exercise' or 'sell-to-cover' transaction) is a common and expected event for executives receiving equity compensation, ensuring compliance with tax laws without requiring the executive to use personal funds for tax payments. This is a standard mechanism seen across industries.
• The acquisition of shares through an Employee Stock Purchase Plan (ESPP) is also a common benefit offered by publicly traded companies, encouraging broader employee ownership and alignment, comparable to programs at companies like Apple (AAPL) or Microsoft (MSFT).

Related Party Transactions

• 55,267 shares are held by the Hogan 2025 GRAT, for which the Reporting Person serves as trustee.
• 1,500 shares are held directly by the spouse of the reporting person, with the reporting person disclaiming beneficial ownership.

Stakeholder Impact

• Shareholders: The grant and vesting of equity awards align the interests of the CEO with long-term shareholder value creation. The tax-related sale is a standard practice and not indicative of a lack of confidence.
• Employees: The mention of the Employee Stock Purchase Plan (ESPP) indicates a broader program for employee ownership, fostering alignment across the company.

Next Steps

• 1/4th of the Restricted Stock Unit granted on February 20, 2026, will vest on February 20, 2027, with shares delivered to the reporting person.
• Subsequent 1/4th portions of the February 20, 2026 RSU grant will vest annually thereafter.
• The Market Stock Unit granted on February 20, 2026, will vest on the last day of the third year of its Performance Period, contingent on performance metrics.
• Remaining portions of Restricted Stock Units granted in 2023, 2024, and 2025 will continue to vest annually.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation, including the vesting of equity awards and a tax-related share disposal. Such transactions are expected and do not typically signal a change in the company's fundamental outlook or the executive's confidence. Therefore, it provides no new information to warrant a change in investment posture, suggesting a 'hold' recommendation based solely on this filing.

Keywords

Align Technology, ALGN, Joseph M. Hogan, Insider Trading, Form 4, Stock Transaction, Restricted Stock Units, Market Stock Units, Equity Compensation, CEO, Director